In The News
Another judge overturns decision for uncritical copying and pasting
Exactech class action continues settlement talks despite US bankruptcy
Judge trims funder’s cut in $38M Mayne Pharma class action settlement
New Zealand’s highest court endorses early common fund orders
Chartered Accountants drops investigation into ex-PwC tax partner
Virbac loses bid to block generic animal drug
Babcock & Brown shareholders can’t stay costs orders in failed 10-year-old case
Law firm can’t dodge $5.4M security in Macquarie class action
‘Truly lamentable’: Solicitors score partial win in tax appeal
Pfizer faces class action investigation into Depo-Provera
Please login to bookmarkClose

Animal health company Virbac has lost its interlocutory bid to block a generic version of its animal drug Cydectin Platinum by rival Abbey Laboratories. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au